MOH
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: likely_approved
Livdelzi (SELADELPAR) regulatory status in United Arab Emirates.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH has authorised it.
GILEAD SCIENCES INC holds the UAE marketing authorisation.